PodcastIntel
Sign in Get Started Free
The Long Run with Luke Timmerman
The Long Run with Luke Timmerman

Ep170: David Schenkein on Investing in the Future of Biotech

Jan 2, 2025 · 00:59:52
Listen to Episode
✨ AI Summary
  • David Schenkein discusses GV's approach to biotech investing.
  • Focus on identifying and supporting transformative scientific innovation.
  • Future of biotech lies in novel therapeutic modalities and platforms.

Guests on This Episode

DS
David Schenkein
Chief Executive Officer - Agios Pharmaceuticals, Inc. · 2 podcast appearances
›

More from The Long Run with Luke Timmerman

The Long Run with Luke Timmerman
Ep211: Ardem Patapoutian on Touch, Pain & New Discoveries in Neuroscience
Oct 7, 2026 · 01:06:37
The Long Run with Luke Timmerman
Ep210: Cameron Turtle on Long-Lasting Antibodies for Immune Disorders
Sep 23, 2026 · 01:03:57
The Long Run with Luke Timmerman
Ep209: Mathai Mammen on Developing Drugs Against Undruggable Targets
Sep 9, 2026 · 01:36:12
The Long Run with Luke Timmerman
Ep208: Gary Nabel on Developing a Vaccine for Epstein-Barr Virus
Aug 25, 2026 · 01:07:17
View all episodes →

Get AI Summaries for Every New Episode

Subscribe to The Long Run with Luke Timmerman and get AI summaries, guest tracking, and email digests delivered automatically.

Sign Up Free →